首页> 外文期刊>Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists >PLATELET-LYMPHOCYTE RATIO AS A NOVEL SURROGATE MARKER TO DIFFERENTIATE THYROTOXIC PATIENTS WITH GRAVES DISEASE FROM SUBACUTE THYROIDITIS: A CROSS-SECTIONAL STUDY FROM SOUTH INDIA
【24h】

PLATELET-LYMPHOCYTE RATIO AS A NOVEL SURROGATE MARKER TO DIFFERENTIATE THYROTOXIC PATIENTS WITH GRAVES DISEASE FROM SUBACUTE THYROIDITIS: A CROSS-SECTIONAL STUDY FROM SOUTH INDIA

机译:血小板淋巴细胞比例作为一种新型替代标志物,以区分雌激素甲状腺炎的甲状腺毒性患者:印度南部的横截面研究

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: Graves disease (GD) and the toxic phase of subacute thyroiditis (SAT) have similar clinical and biochemical presentations, and differentiating them requires sophisticated investigations. Since thyroid hormones have been noted to affect all hematologic cell lines, we have used the platelet lymphocyte ratio (PLR)-an index usually utilized in inflammatory or malignant disorders-to compare patients with and without thyrotoxicosis and to analyze its use in distinguishing between patients with GD and SAT prior to therapy.
机译:None

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号